Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future

被引:8
|
作者
Gao, Feng [1 ]
Chen, Gang [2 ,3 ,4 ]
Byrne, Christopher D. [5 ,6 ]
Targher, Giovanni [7 ,8 ]
Cheung, Tan To [9 ]
Zheng, Ming-Hua [10 ,11 ,12 ,13 ]
机构
[1] Wenzhou Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Wenzhou, Peoples R China
[3] Wenzhou Med Univ, Key Lab Diag & Treatment Severe Hepatopancreat Dis, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Hepatobiliary Pancreat Tumor Bioengn Cross Int Joi, Affiliated Hosp 1, Wenzhou, Peoples R China
[5] Univ Hosp Southampton, Southampton Natl Inst Hlth & Care Res, Biomed Res Ctr, Southampton, England
[6] Univ Southampton, Southampton Gen Hosp, Southampton, England
[7] Univ Verona, Dept Med, Verona, Italy
[8] IRCCS Sacro Cuore Don Calabria Hosp, I-37024 Negrar Di Valpolicella, Italy
[9] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Peoples R China
[10] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, NAFLD Res Ctr, Wenzhou, Peoples R China
[11] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China
[12] Key Lab Diag & Treatment Dev Chron Liver Dis Zheji, Wenzhou, Peoples R China
[13] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, MAFLD Res Ctr, 2 Fuxue Lane, Wenzhou 325000, Peoples R China
基金
中国国家自然科学基金;
关键词
Metabolic dysfunction-associated fatty liver disease (MAFLD); metabolic dysfunction-associated steatotic liver disease; nonalcoholic fatty liver disease; hepatocellular carcinoma (HCC); epidemiology;
D O I
10.21037/hbsn-23-539
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:945 / 948
页数:4
相关论文
共 50 条
  • [31] Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
    Eduardo Fassio
    Fernando J Barreyro
    M Soledad Pérez
    Diana Dávila
    Graciela Landeira
    Gisela Gualano
    Gabriela Ruffillo
    World Journal of Hepatology, 2022, 14 (02) : 354 - 371
  • [32] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Wang, Ting-Yao
    Wang, Rui-Fang
    Bu, Zhi-Ying
    Targher, Giovanni
    Byrne, Christopher D.
    Sun, Dan-Qin
    Zheng, Ming-Hua
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (04) : 259 - 268
  • [33] Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
    Salazar, Melchor Alpizar
    Reyes, Samantha Estefania Olguin
    Estevez, Andrea Medina
    Lobos, Julieta Alejandra Saturno
    Castillo, Jesus Manuel De Aldecoa
    Aguas, Juan Carlos Carrera
    Monreal, Samary Alaniz
    Rodriguez, Jose Antonio Navarro
    Sanchez, Dulce Maria Fernanda Alpizar
    MEDICINA-LITHUANIA, 2025, 61 (01):
  • [34] Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on "Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis"
    Nakamura, Toru
    Nakano, Masahito
    Tsutsumi, Tsubasa
    Amano, Keisuke
    Kawaguchi, Takumi
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [35] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    Han, A. Lum
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [36] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    A Lum Han
    Diabetology & Metabolic Syndrome, 14
  • [37] Metabolic Dysfunction-Associated Steatotic Liver Disease vs. Metabolic Dysfunction-Associated Fatty Liver Disease: Which Option is the Better Choice?
    Gambardella, Maria Luisa
    Abenavoli, Ludovico
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2025, 86 (02)
  • [38] Metabolic dysfunction-associated steatotic liver disease: A pathophysiology and clinical framework to face the present and the future
    Corrao, Salvatore
    Calvo, Luigi
    Grana, Walter
    Scibetta, Salvatore
    Mirarchi, Luigi
    Amodeo, Simona
    Falcone, Fabio
    Argano, Christiano
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2025, 35 (02)
  • [39] Impact of metabolic dysfunction-associated fatty liver disease on liver transplant recipients with hepatitis B virus-related hepatocellular carcinoma
    Ji-Qiao Zhu
    Xiao-Yong Ye
    Shi-Wei Yang
    Jia-Zong Liu
    Zhang-Yong Ren
    Ya-Nan Jia
    Zhe Liu
    Cheng Ding
    Jian-Tao Kou
    Xian-Liang Li
    Dong-Dong Han
    Qiang He
    European Journal of Clinical Nutrition, 2024, 78 : 107 - 113
  • [40] Impact of metabolic dysfunction-associated fatty liver disease on liver transplant recipients with hepatitis B virus-related hepatocellular carcinoma
    Zhu, Ji-Qiao
    Ye, Xiao-Yong
    Yang, Shi-Wei
    Liu, Jia-Zong
    Ren, Zhang-Yong
    Jia, Ya-Nan
    Liu, Zhe
    Ding, Cheng
    Kou, Jian-Tao
    Li, Xian-Liang
    Han, Dong-Dong
    He, Qiang
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2024, 78 (02) : 107 - 113